Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Vertex Pharmaceuticals
(NQ:
VRTX
)
471.44
+3.85 (+0.82%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 14, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Vertex Pharmaceuticals
< Previous
1
2
3
4
5
6
7
8
9
...
45
46
Next >
2 Top Growth Stocks to Buy With $1,000 Right Now
February 18, 2024
Even a modest starting investment in the right stocks could pay off in the years ahead.
Via
The Motley Fool
Vertex Pharmaceuticals Will Use $100 Million to Tank Its Own Market Share. Here's Why That's a Smart Move.
February 17, 2024
Sometimes, the winning move doesn't look right at first.
Via
The Motley Fool
2 Healthcare Growth Stocks That Are No-Brainer Buys Right Now
February 17, 2024
The healthcare industry often remains resilient amid macro headwinds, and these two stocks are prime examples.
Via
The Motley Fool
Giving Uber Its Due
February 15, 2024
We've also got a look at good news from Chipotle and Roblox, and we put some stocks on a dating show.
Via
The Motley Fool
Want $1 Million in Retirement? Invest $250,000 in These 3 Stocks and Wait a Decade.
February 15, 2024
These stocks have what it takes to drive superior returns in the years to come.
Via
The Motley Fool
Is Vertex Pharmaceuticals Stock Too Expensive With a Price-to-Sales Ratio of 11x?
February 15, 2024
There's more to consider with Vertex's valuation than one number.
Via
The Motley Fool
Stock-Split Watch: Is Vertex Pharmaceuticals Next?
February 14, 2024
It's on track to launch more blockbuster drugs.
Via
The Motley Fool
Could Vertex Pharmaceuticals Reach $500 in 2024?
February 10, 2024
Vertex shares have several catalysts on the horizon...
Via
The Motley Fool
Vertex Pharmaceuticals Stock Is Approaching a Huge Catalyst, But Is It a Buy?
February 08, 2024
Its pain medicine isn't precisely what it hoped for, but it could still sell.
Via
The Motley Fool
If You Invested $10,000 in Vertex Pharmaceuticals in 2014, This Is How Much You Would Have Today
February 13, 2024
You can't go back in the past, but it's not too late to invest in this top stock.
Via
The Motley Fool
2 Healthcare Stocks That Could Help Set You Up for Life
February 12, 2024
These rock-solid businesses can add meaningful returns to a long-term portfolio.
Via
The Motley Fool
3 Groundbreaking Healthcare Stocks to Buy for Robust Gains
February 11, 2024
Get the latest investment advice for healthcare stocks in 2024. Discover top picks and growth opportunities for the healthcare sector.
Via
InvestorPlace
Is Vertex Pharmaceuticals Stock a Buy Now?
February 10, 2024
The company just released its latest earnings report, and growth investors may be a little disappointed.
Via
The Motley Fool
2 Healthcare Stocks You Can Buy and Hold for the Next Decade
February 10, 2024
These businesses are built to last.
Via
The Motley Fool
2 No-Brainer Healthcare Stocks to Buy Right Now
February 10, 2024
Companies in the healthcare industry tend to generate returns in a wide range of market environments.
Via
The Motley Fool
$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today
February 07, 2024
Via
Benzinga
This High-Flying Stock Just Got Some Bad News: Should You Sell?
February 06, 2024
It's just a minor setback for this leading biotech.
Via
The Motley Fool
Vertex's Next-Gen Cystic Fibrosis Drug Scores Big; Shares Rise On Quarterly Beat
February 05, 2024
The company also topped fourth-quarter expectations.
Via
Investor's Business Daily
3 Stocks That Could Trounce the Market in 2024
February 10, 2024
These stocks appear to have what it takes to beat the market this year.
Via
The Motley Fool
3 Growth Stocks With More Potential Than Any Cryptocurrency
February 09, 2024
The stock market is full of opportunities for investors of all risk appetites and trading styles.
Via
The Motley Fool
3 Strong Buy Healthcare Stocks to Add to Your February Must-Watch List
February 09, 2024
These strong buy healthcare stocks are among analysts' favorite picks, and their strong market position tells us why.
Via
InvestorPlace
Stock Market Hits Highs As AI Plays Arm, Palantir Skyrocket: Weekly Review
February 08, 2024
The S&P 500 hit 5,000. Arm, Palantir and Cloudflare rose sharply.
Via
Investor's Business Daily
Topics
Artificial Intelligence
Stocks
Exposures
Artificial Intelligence
US Equities
Vertex's Next-Generation Cystic Fibrosis Program Shows Efficacy With Reduced Burden, Provides Growth Opportunity: Goldman Sachs
February 06, 2024
Vertex Pharmaceuticals' cystic fibrosis treatment with vanza triple therapy. SKYLINE trials show non-inferiority to Trikafta, emphasizing once-daily dosing benefits.
Via
Benzinga
Vertex Pharmaceuticals' Triple Combo Treatment For Lung Disorder Meets Primary Goal In Adult And Pediatric Patients
February 06, 2024
Vertex Pharmaceuticals' vanza triple program for cystic fibrosis, with superior results in lung function, sweat chloride reduction, and safety.
Via
Benzinga
Vertex Pharmaceuticals Has a $10 Billion Opportunity on the Table. Here's How You Can Invest
February 06, 2024
Its foray into developing analgesics seems to be going swimmingly.
Via
The Motley Fool
Uber To Rally Around 15%? Here Are 10 Top Analyst Forecasts For Tuesday
February 06, 2024
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
Via
Benzinga
The 7 Best Healthcare Stocks to Invest In for Big Gains in 2024
February 06, 2024
Invest in the future with healthcare stocks 2024; offering a blend of market stability and cutting-edge medical advancements.
Via
InvestorPlace
Vertex Pharmaceuticals (VRTX) Q4 2023 Earnings Call Transcript
February 05, 2024
VRTX earnings call for the period ending December 31, 2023.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
Stocks Fall As Traders Dial Back Rate Cut Bets; Dollar, Treasury Yields Rise: What's Driving Markets Monday?
February 05, 2024
Wall Street ends week on negative note as traders revise down expectations on Fed rate cuts. Strong economic data and Fed officials' comments push stocks into red, reducing rate cut expectations for...
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
Vertex Pharmaceuticals Gears Up For Q4 Print; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call
February 05, 2024
Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX) is expected to release earnings results for its fourth quarter, after the closing bell on Feb. 5, 2024.
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
...
45
46
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.